Asthma pharmacogenetics and the development of genetic profiles for personalized medicine
Victor E Ortega, Deborah A Meyers, Eugene R Bleecker Center for Genomics and Personalized Medicine Research, Pulmonary Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA Abstract: Human genetics research will be critical to the development of genetic profiles for personalized or preci...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-01-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Online Access: | http://www.dovepress.com/asthma-pharmacogenetics-and-the-development-of-genetic-profiles-for-pe-peer-reviewed-article-PGPM |
| _version_ | 1818805883473231872 |
|---|---|
| author | Ortega VE Meyers DA Bleecker ER |
| author_facet | Ortega VE Meyers DA Bleecker ER |
| author_sort | Ortega VE |
| collection | DOAJ |
| description | Victor E Ortega, Deborah A Meyers, Eugene R Bleecker Center for Genomics and Personalized Medicine Research, Pulmonary Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA Abstract: Human genetics research will be critical to the development of genetic profiles for personalized or precision medicine in asthma. Genetic profiles will consist of gene variants that predict individual disease susceptibility and risk for progression, predict which pharmacologic therapies will result in a maximal therapeutic benefit, and predict whether a therapy will result in an adverse response and should be avoided in a given individual. Pharmacogenetic studies of the glucocorticoid, leukotriene, and β2-adrenergic receptor pathways have focused on candidate genes within these pathways and, in addition to a small number of genome-wide association studies, have identified genetic loci associated with therapeutic responsiveness. This review summarizes these pharmacogenetic discoveries and the future of genetic profiles for personalized medicine in asthma. The benefit of a personalized, tailored approach to health care delivery is needed in the development of expensive biologic drugs directed at a specific biologic pathway. Prior pharmacogenetic discoveries, in combination with additional variants identified in future studies, will form the basis for future genetic profiles for personalized tailored approaches to maximize therapeutic benefit for an individual asthmatic while minimizing the risk for adverse events. Keywords: asthma, pharmacogenetics, response heterogeneity, single nucleotide polymorphism, genome-wide association study |
| first_indexed | 2024-12-18T19:00:57Z |
| format | Article |
| id | doaj.art-0acaa4536b2e4d378c219469689c5d65 |
| institution | Directory Open Access Journal |
| issn | 1178-7066 |
| language | English |
| last_indexed | 2024-12-18T19:00:57Z |
| publishDate | 2015-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Pharmacogenomics and Personalized Medicine |
| spelling | doaj.art-0acaa4536b2e4d378c219469689c5d652022-12-21T20:56:30ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662015-01-012015default92220021Asthma pharmacogenetics and the development of genetic profiles for personalized medicineOrtega VEMeyers DABleecker ERVictor E Ortega, Deborah A Meyers, Eugene R Bleecker Center for Genomics and Personalized Medicine Research, Pulmonary Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA Abstract: Human genetics research will be critical to the development of genetic profiles for personalized or precision medicine in asthma. Genetic profiles will consist of gene variants that predict individual disease susceptibility and risk for progression, predict which pharmacologic therapies will result in a maximal therapeutic benefit, and predict whether a therapy will result in an adverse response and should be avoided in a given individual. Pharmacogenetic studies of the glucocorticoid, leukotriene, and β2-adrenergic receptor pathways have focused on candidate genes within these pathways and, in addition to a small number of genome-wide association studies, have identified genetic loci associated with therapeutic responsiveness. This review summarizes these pharmacogenetic discoveries and the future of genetic profiles for personalized medicine in asthma. The benefit of a personalized, tailored approach to health care delivery is needed in the development of expensive biologic drugs directed at a specific biologic pathway. Prior pharmacogenetic discoveries, in combination with additional variants identified in future studies, will form the basis for future genetic profiles for personalized tailored approaches to maximize therapeutic benefit for an individual asthmatic while minimizing the risk for adverse events. Keywords: asthma, pharmacogenetics, response heterogeneity, single nucleotide polymorphism, genome-wide association studyhttp://www.dovepress.com/asthma-pharmacogenetics-and-the-development-of-genetic-profiles-for-pe-peer-reviewed-article-PGPM |
| spellingShingle | Ortega VE Meyers DA Bleecker ER Asthma pharmacogenetics and the development of genetic profiles for personalized medicine Pharmacogenomics and Personalized Medicine |
| title | Asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| title_full | Asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| title_fullStr | Asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| title_full_unstemmed | Asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| title_short | Asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| title_sort | asthma pharmacogenetics and the development of genetic profiles for personalized medicine |
| url | http://www.dovepress.com/asthma-pharmacogenetics-and-the-development-of-genetic-profiles-for-pe-peer-reviewed-article-PGPM |
| work_keys_str_mv | AT ortegave asthmapharmacogeneticsandthedevelopmentofgeneticprofilesforpersonalizedmedicine AT meyersda asthmapharmacogeneticsandthedevelopmentofgeneticprofilesforpersonalizedmedicine AT bleeckerer asthmapharmacogeneticsandthedevelopmentofgeneticprofilesforpersonalizedmedicine |